SCR-LIP-000364 · Claim · machine-readable JSON →

In a cross-sectional survey of 969 Spanish lipedema patients, diagnoses used the Schingale type I-IV classification (type III 41.7%, type IV 36.8%, type II 17.8%, type I 3.7%) and a modified Wolf/Herbst 13-criteria symptom scale; the authors validated a threshold of ≥6 of 13 symptoms (Mann-Whitney p=0.666 showing no distributional difference between diagnosed and undiagnosed groups), and diagnosis often required multiple consultations (51.2% needed ≥3 specialists).

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
1 source(s)
Dates
2026-05-31 → 2026-06-12

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

2023The Advanced Care Study: Current Status of Lipedema in Spain, A Descriptive Cross-Sectional Study — Carballeira Braña & Poveda Castillo (2023) · consistent

Evidence (1)

Context (PECO)

PopulationSpanish women with lipedema (n=969)
Conditionlipedema
ExposureSchingale type I-IV classification and 13-criteria symptom scale
Comparatordiagnosed vs. undiagnosed groups
Outcomediagnostic threshold validity (≥6 of 13 symptoms)
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log